ARCHIVES

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

DCPC Board Asks More Money For Cancer Control In Centers, Urges Support Of Measure On Employment Discrimination

October 3, 1986

Holland, Hoogstraten Give Up Chairmanships Of CALGB, SWOG

March 6, 1981

In Brief: Mass. Selects Hoh As Health Commissioner; Komen Foundation Selects Research Fellows

August 8, 1997

NIH Cool On OIG, But the Awardees Love it, DeVita Says

October 17, 1986

Data Falsification Charge To Be Aired

June 27, 1980

Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS.

February 15, 2002